STOCK TITAN

Amesite Inc. Form 4 Filings

AMST NASDAQ

Every Form 4 that Amesite Inc. (AMST) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow AMST and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AMST filings page.

Rhea-AI Summary

Amesite Inc. reported that Chief Financial Officer Sarah Berman received a grant of stock options as part of her compensation. The award covers 10,000 options to purchase common stock at an exercise price of $1.1400 per share, expiring on June 29, 2036. According to the vesting terms, 25% of the options vest on June 29, 2027, and the remaining options vest in equal monthly installments over the following 36 months. After this grant, she holds 10,000 stock options directly.

Rhea-AI Summary

Amesite Inc. chief financial officer Sarah Berman reported a compensation-related stock option grant. She received options to buy 2,500 shares of common stock at an exercise price of $3.05 per share, expiring on May 22, 2035. According to the vesting terms under the 2018 Equity Incentive Plan, 25% of the shares vest on May 22, 2026, with the remaining shares vesting in equal monthly installments over 36 months.

Rhea-AI Summary

Parmer George reported acquisition or exercise transactions in this Form 4 filing.

Amesite Inc. director George Parmer received a grant of 9,023 restricted stock units as compensation. These RSUs were issued as deferred stock units in lieu of cash fees earned for serving as a director, with the number based on the closing share price on the last day of the quarter.

Each unit represents a right to receive one share of Amesite common stock or the cash equivalent. The deferred stock units or cash equivalent will be delivered after Parmer completes service on the board or upon an earlier change in control. Following this award, his directly held equity position reported in this filing totals 76,910 shares or share-equivalent units.

Rhea-AI Summary

OMENN GILBERT S reported acquisition or exercise transactions in this Form 4 filing.

Amesite Inc. director Gilbert S. Omenn, through the Gilbert S. Omenn Revocable Trust, received a grant of 9,023 restricted stock units as compensation for board service. Each RSU represents a contingent right to one share of common stock or its cash equivalent, to be delivered after board service ends or upon a change in control. Following this award, indirect holdings reported for this trust total 83,806 shares underlying RSUs.

Rhea-AI Summary

LOSH J MICHAEL reported acquisition or exercise transactions in this Form 4 filing.

Amesite Inc. director J. Michael Losh, through the J. Michael Losh Irrevocable Qualified Annuity Trust #7, received a grant of 10,902 restricted stock units as deferred stock units in lieu of cash director fees. Each unit represents one share of AMST common stock or its cash equivalent, deliverable after board service ends or upon an earlier change in control. Following this award, the trust holds 101,265 units in total.

Rhea-AI Summary

Brewer Barbie reported acquisition or exercise transactions in this Form 4 filing.

Amesite Inc. director Barbie Brewer received a grant of 10,432 restricted stock units as board compensation. Each RSU represents a right to receive one share of common stock or its cash equivalent. The units were issued in lieu of cash fees and will be settled when board service ends or upon a change in control.

Rhea-AI Summary

Amesite Inc. director and chief executive officer Ann Marie Sastry reported buying additional equity on April 28, 2026. She purchased 174,216 shares of common stock at $1.435 per share in a private placement pursuant to a securities purchase agreement and now holds 1,049,647 common shares directly. On the same date, she also acquired Series A-1 and Series A-2 warrants, each covering 174,216 underlying common shares at a $1.435 exercise price, with expirations on April 28, 2031 and October 28, 2027, respectively.

Rhea-AI Summary

Amesite Inc. director George Parmer reported a net purchase of Amesite securities. He bought 243,902 shares of Common Stock at $1.435 per share in a private placement pursuant to a securities purchase agreement. Following this, he directly holds 566,962 Common shares.

Parmer also acquired 243,902 Series A-2 Warrants and 243,902 Series A-1 Warrants, each giving the right to buy Common Stock at an exercise price of $1.435 per share. The Series A-2 Warrants expire on October 28, 2027, and the Series A-1 Warrants expire on April 28, 2031. These transactions were made in connection with the same private placement offering described in an Amesite 424(b)(5) prospectus supplement.

Rhea-AI Summary

OMENN GILBERT S reported acquisition or exercise transactions in this Form 4 filing.

Amesite Inc. director Gilbert S. Omenn, through the Gilbert S. Omenn Revocable Trust, received a grant of 6,522 restricted stock units on March 31, 2026. Each unit represents one share of Amesite common stock or its cash equivalent, awarded in lieu of cash director fees based on the quarter-end closing share price. The deferred stock units or cash equivalent will be delivered after he leaves the board or upon an earlier change in control. Following this award, the trust’s indirect holdings reported in this line total 74,783 shares.

Rhea-AI Summary

Brewer Barbie reported acquisition or exercise transactions in this Form 4 filing.

Amesite Inc. director Barbie Brewer received a grant of 7,541 restricted stock units. These RSUs were awarded as deferred stock units in lieu of cash fees for her board service, with the number of units based on the closing share price on the last day of the quarter.

Each RSU represents the right to receive one share of Amesite common stock or its cash equivalent. The deferred stock units or cash equivalent will be delivered after she completes service on the board or upon an earlier change in control. Following this grant, she holds 30,322 shares or equivalents directly.

Rhea-AI Summary

Parmer George reported acquisition or exercise transactions in this Form 4 filing.

Amesite Inc. director George Parmer received a grant of 6,522 restricted stock units. These RSUs were issued as deferred stock units in lieu of cash compensation for his board service, with the number of units based on Amesite’s closing share price on the last day of the quarter.

Each RSU represents a contingent right to receive one share of Amesite common stock or its cash equivalent. The deferred stock units or cash equivalent will be delivered after Parmer’s board service ends or upon an earlier change in control. Following this award, he holds 67,887 shares or share-equivalent units directly.

Rhea-AI Summary

LOSH J MICHAEL reported acquisition or exercise transactions in this Form 4 filing.

Amesite Inc. director J. Michael Losh had 7,880 restricted stock units credited to the J. Michael Losh Irrevocable Qualified Annuity Trust #7. These units were issued as deferred stock units in lieu of cash fees for board service and are tied to the closing share price on the last day of the quarter.

Each restricted stock unit represents a contingent right to receive one share of Amesite common stock or its cash equivalent. The deferred stock units or cash equivalent will be delivered after Mr. Losh’s service on the board ends or upon an earlier change in control. Following this grant, the trust is reported as holding 90,363 deferred/restricted stock units in total, all indirectly associated with Mr. Losh.

Rhea-AI Summary

Amesite Inc. director Parmer George exercised restricted stock units into common shares, increasing his direct equity stake. On March 7, 2026, 41,322 restricted stock units converted into 41,322 shares of Amesite common stock at a stated price of $0.00 per share. Following the transaction, George directly owned 323,060 shares of common stock. The reported restricted stock units were originally granted on March 7, 2025 and vested on March 7, 2026, with each unit representing a right to receive one share of common stock or its cash equivalent. No open-market purchases or sales were reported in this filing.

Rhea-AI Summary

Amesite Inc. director Barbie Brewer exercised restricted stock units that had vested into common shares. On March 7, 2026, she converted 41,322 restricted stock units into 41,322 shares of Amesite common stock at a stated price of $0.00 per share as part of her equity compensation.

These restricted stock units were originally granted on March 7, 2025 and vested on March 7, 2026. Following the conversion, Brewer directly holds 135,977 shares of Amesite common stock, and there are no remaining derivative positions from this RSU grant disclosed in the filing.

Rhea-AI Summary

Amesite Inc. director Gilbert S. Omenn, through the Gilbert S. Omenn Revocable Trust, exercised 41,322 restricted stock units into the same number of Amesite common shares on March 7, 2026. These RSUs were granted on March 7, 2025 and vested one year later. Following the transaction, the trust holds 143,699 shares of Amesite common stock indirectly. This is a compensation-related derivative exercise with no open-market buying or selling disclosed.

Rhea-AI Summary

Amesite Inc. director J. Michael Losh reported a routine equity compensation event involving restricted stock units held through a trust. On March 7, 2026, the J. Michael Losh Irrevocable Qualified Annuity Trust #7 exercised 41,322 restricted stock units granted on March 7, 2025, converting them into 41,322 shares of Amesite common stock at no cash exercise price. Following the conversion, the trust holds 138,200 shares of common stock indirectly on behalf of Losh. Each restricted stock unit represented a right to receive one share of Amesite common stock or its cash equivalent upon vesting.

Rhea-AI Summary

Amesite Inc. director J. Michael Losh reported an equity compensation award made through an associated trust. On February 6, 2026, the J. Michael Losh Irrevocable Qualified Annuity Trust #7 received 49,751 restricted stock units (RSUs) of Amesite at a price of $0 per unit.

Each RSU represents a contingent right to receive one share of Amesite common stock or its cash equivalent. The RSUs fully vest on the first anniversary of the grant date, after which the trust will be entitled to the underlying shares or cash value.

Rhea-AI Summary

Amesite Inc. director Gilbert S. Omenn, through the Gilbert S. Omenn Revocable Trust, reported an award of 49,751 restricted stock units (RSUs) of Amesite Inc. on February 6, 2026, at a price of $0 per unit.

Each RSU represents a contingent right to receive one share of Amesite common stock and/or the cash equivalent of one share. The RSUs fully vest on the first anniversary of the grant date, and the trust holds 49,751 derivative securities after this transaction.

Rhea-AI Summary

Amesite Inc. director George Parmer reported an equity award in the form of derivative securities. On February 6, 2026, he received 49,751 restricted stock units (RSUs) at a price of $0 per unit. Each RSU represents a contingent right to receive one share of AMST common stock and/or the cash equivalent.

The RSUs fully vest on the first anniversary of the grant date, and Parmer now directly holds 49,751 derivative securities linked to Amesite common stock as a result of this award.

Rhea-AI Summary

Amesite Inc. director Barbie Brewer received a grant of 49,751 restricted stock units (RSUs) on February 6, 2026. Each RSU represents a right to receive one share of Amesite common stock or its cash equivalent. The RSUs fully vest on the first anniversary of the grant date, giving Brewer potential future ownership if service-based conditions are satisfied.

Rhea-AI Summary

Amesite Inc. (AMST) reported a Section 16 filing showing that on 09/30/2025 the reporting person received 3,934 restricted stock units (RSUs) as deferred compensation for board service. Each RSU represents a contingent right to one share of common stock or a cash equivalent calculated using the closing price on the quarter end. The RSUs were issued in lieu of cash director fees and will be delivered upon completion of board service or earlier upon a change in control. After the transaction, the reporting person beneficially owns 61,912 shares indirectly through the Gilbert S. Omenn Revocable Trust. The Form 4 was executed by an attorney-in-fact on 10/02/2025.

Rhea-AI Summary

George Parmer, a director of Amesite Inc. (AMST), was issued 3,934 restricted stock units (RSUs) on 09/30/2025 as deferred compensation in lieu of cash. Each RSU represents a contingent right to one share of AMST common stock or a cash equivalent, and the number of units was calculated using the closing share price on the last day of the quarter. The RSUs are payable upon completion of Mr. Parmer's board service or, if earlier, a change in control. Following this grant, Mr. Parmer beneficially owns 55,016 shares of AMST common stock. The units were reported with an indicated price of $0 because they represent deferred compensation, not a cash purchase.

Rhea-AI Summary

Amesite Inc. (AMST) director J. Michael Losh was granted 4,754 restricted stock units (RSUs) on 09/30/2025 as deferred compensation in lieu of cash. Each RSU represents a contingent right to one share of AMST common stock or the cash equivalent. The RSUs were calculated using the closing share price on the last day of the quarter and will be delivered upon completion of board service or earlier upon a change in control. After this transaction, the reporting person beneficially owns 74,811 shares of common stock indirectly through the J. Michael Losh Irrevocable Qualified Annuity Trust #7. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Losh and filed on 10/02/2025.